Iranian Journal of Neurology 2017. 16(2):.

S100 B: A new concept in neurocritical care
Omidvar Rezaei, Hossein Pakdaman, Kurosh Gharehgozli, Leila Simani, Amir Vahedian-Azimi, Sina Asadi, Zahra Sahraei, Mohammadreza Hajiesmaeili

Abstract


-

Keywords


Brain Marker, Neurobiochemical Marker, Neurocritical Care, Pathognomonic Marker, S100B Protein

References


Johnsson, P., Markers of cerebral ischemia after cardiac surgery. Journal of cardiothoracic and vascular anesthesia, 1996. 10(1): p. 120-126.

Vaage, J. and R. Anderson, Biochemical markers of neurologic injury in cardiac surgery: The rise and fall of S100β. The Journal of thoracic and cardiovascular surgery, 2001. 122(5): p. 853-855.

Hajiesmaeili, M., et al., Biochemical markers in Neurocritical Care. Journal of Cellular and Molecular Anesthesia, 2016. 1(3): p. 115-119.

Yardan, T., et al., Usefulness of S100B protein in neurological disorders. J Pak Med Assoc, 2011. 61(3): p. 276-281.

Green, A., et al., Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia. Neuroscience letters, 1997. 235(1): p. 5-8.

Zetterberg, H., D.H. Smith, and K. Blennow, Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nature Reviews Neurology, 2013. 9(4): p. 201-210.

Liu, W., et al., S100β in heavy metal-related child attention-deficit hyperactivity disorder in an informal e-waste recycling area. Neurotoxicology, 2014. 45: p. 185-191.

Brunnekreef, G., et al., Measurements of Cerebrospinal Fluid Concentrations of S100β Protein During and After Thoracic Endovascular Stent Grafting. European journal of vascular and endovascular surgery, 2007. 34(2): p. 169-172.

Qin, B., K.S. Panickar, and R.A. Anderson, Cinnamon polyphenols attenuate the hydrogen peroxide-induced down regulation of S100β secretion by regulating sirtuin 1 in C6 rat glioma cells. Life sciences, 2014. 102(1): p. 72-79.

Qin, B., K.S. Panickar, and R.A. Anderson, Cinnamon polyphenols regulate S100β, sirtuins, and neuroactive proteins in rat C6 glioma cells. Nutrition, 2014. 30(2): p. 210-217.

Donato, R., et al., S100B's double life: intracellular regulator and extracellular signal. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 2009. 1793(6): p. 1008-1022.

Gerlach, R., et al., Active secretion of S100B from astrocytes during metabolic stress. Neuroscience, 2006. 141(4): p. 1697-1701.

de Souza, D.F., et al., S100B secretion is stimulated by IL-1β in glial cultures and hippocampal slices of rats: likely involvement of MAPK pathway. Journal of neuroimmunology, 2009. 206(1): p. 52-57.

Donato, R., S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The international journal of biochemistry & cell biology, 2001. 33(7): p. 637-668.

Selinfreund, R.H., et al., Neurotrophic protein S100 beta stimulates glial cell proliferation. Proceedings of the National Academy of Sciences, 1991. 88(9): p. 3554-3558.

Rothermundt, M., et al., S100B in brain damage and neurodegeneration. Microscopy research and technique, 2003. 60(6): p. 614-632.

Sen, J. and A. Belli, S100B in neuropathologic states: the CRP of the brain? Journal of neuroscience research, 2007. 85(7): p. 1373-1380.

Hu, J., A. Ferreira, and L.J. Van Eldik, S100β induces neuronal cell death through nitric oxide release from astrocytes. Journal of neurochemistry, 1997. 69(6): p. 2294-2301.

Iuvone, T., et al., Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. Journal of Molecular Medicine, 2007. 85(12): p. 1379-1392.

Kerkhoff, C., M. Klempt, and C. Sorg, Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1998. 1448(2): p. 200-211.

Donato, R., Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1999. 1450(3): p. 191-231.

Hofmann, M.A., et al., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell, 1999. 97(7): p. 889-901.

Bianchi, R., et al., S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. Journal of Biological Chemistry, 2011. 286(9): p. 7214-7226.

Villarreal, A., et al., S100B alters neuronal survival and dendrite extension via RAGE‐mediated NF‐κB signaling. Journal of neurochemistry, 2011. 117(2): p. 321-332.

Huttunen, H.J., et al., Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. Journal of Biological Chemistry, 2000. 275(51): p. 40096-40105.

Kögel, D., et al., S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience, 2004. 127(4): p. 913-920.

Businaro, R., et al., S100B protects LAN‐5 neuroblastoma cells against Aβ amyloid‐induced neurotoxicity via RAGE engagement at low doses but increases Aβ amyloid neurotoxicity at high doses. Journal of neuroscience research, 2006. 83(5): p. 897-906.

KA, P., S100 protein family and its application in clinical practice. Hippokratia, 2008. 12(4): p. 198-204.

Gazzolo, D., et al., Human milk contains S100B protein. Biochimica et Biophysica Acta (BBA)-General Subjects, 2003. 1619(2): p. 209-212.

Kleindienst, A., et al., The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Progress in brain research, 2007. 161: p. 317-325.

Heidari, K., et al., Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography. Brain injury, 2015. 29(1): p. 33-40.

Nylén, K., et al., Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta neurochirurgica, 2008. 150(3): p. 221-227.

Biberthaler, P., et al., Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study. Shock, 2006. 25(5): p. 446-453.

Vos, P.E., et al., Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology, 2004. 62(8): p. 1303-1310.

Jagoda, A.S., et al., Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Journal of Emergency Nursing, 2009. 35(2): p. e5-e40.

Undén, J., T. Ingebrigtsen, and B. Romner, Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC medicine, 2013. 11(1): p. 1.

Lin, J., et al., Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. Journal of Biological Chemistry, 2001. 276(37): p. 35037-35041.

Stranjalis, G., et al., Serum S-100B as an indicator of early postoperative deterioration after meningioma surgery. Clinical chemistry, 2005. 51(1): p. 202-207.

Ilhan-Mutlu, A., L. Wagner, and M. Preusser, Circulating biomarkers of CNS tumors: an update. Biomarkers in medicine, 2013. 7(2): p. 267-285.

Song, W., et al., [Serum S100 protein and radiation-induced brain injury in astrocytoma patients]. Di 1 jun yi da xue xue bao= Academic journal of the first medical college of PLA, 2005. 25(6): p. 723-725.

Ortiz-Munoz, B., et al., [S100 protein in tumours of the central nervous system]. Revista de neurologia, 2002. 36(11): p. 1011-1015.

Gartner, W., et al., Elevated blood markers 1 year before manifestation of malignant glioma. Neuro-oncology, 2010. 12(9): p. 1004-1008.

VOS, M.J., et al., Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study. Anticancer research, 2004. 24(4): p. 2511-2514.

Jauch, E.C., et al., Association of Serial Biochemical Markers With Acute Ischemic Stroke The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Stroke, 2006. 37(10): p. 2508-2513.

Missler, U., et al., S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke, 1997. 28(10): p. 1956-1960.

Nash, D.L., M.F. Bellolio, and L.G. Stead, S100 as a marker of acute brain ischemia: a systematic review. Neurocritical care, 2008. 8(2): p. 301-307.

Purrucker, J.C., et al., Serum protein S100β is a diagnostic biomarker for distinguishing posterior circulation stroke from vertigo of nonvascular causes. European neurology, 2014. 72(5-6): p. 278-284.

Kartal, A.G., et al., Diagnostic value of S100B protein in the differential diagnosis of acute vertigo in the emergency department. Academic Emergency Medicine, 2014. 21(7): p. 736-741.

Ishibashi, H. and Y. Funakoshi, Serum S-100B protein levels in left-and right-hemisphere strokes. Journal of Clinical Neuroscience, 2008. 15(5): p. 520-525.

Foerch, C., et al., Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Archives of neurology, 2005. 62(7): p. 1130-1134.

Foerch, C., et al., Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke, 2004. 35(9): p. 2160-2164.

Delgado, P., et al., Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke, 2006. 37(11): p. 2837-2839.

Węglewski, A., et al., Changes in the concentration of protein S100B in the blood serum of ischemic and hemorrhagic brain depending on the size of the fire percussion. Neurol. Neurochir. Pol, 2005. 39: p. 310-317.

Raabe, A., et al., S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurological research, 2004. 26(4): p. 440-445.

Fisher, C., J. Kistler, and J. Davis, Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery, 1980. 6(1): p. 1-9.

Teasdale, G., et al., A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. Journal of neurology, neurosurgery, and psychiatry, 1988. 51(11): p. 1457.

Sanchez-Peña, P., et al., S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage*. Critical care medicine, 2008. 36(8): p. 2267-2273.

Moritz, S., et al., The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. Journal of neurosurgical anesthesiology, 2010. 22(1): p. 21-31.

Weiss, N., et al., Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. The Journal of the American Society of Anesthesiologists, 2006. 104(4): p. 658-666.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.